Curcumin treatment improves motor behavior in α-synuclein transgenic mice

Kateri J. Spinelli, Valerie R. Osterberg, Charles K. Meshul, Amala Soumyanath, Vivek Unni

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The curry spice curcumin plays a protective role in mouse models of neurodegenerative diseases, and can also directly modulate aggregation of α-synuclein protein in vitro, yet no studies have described the interaction of curcumin and α-synuclein in genetic synucleinopathy mouse models. Here we examined the effect of chronic and acute curcumin treatment in the Syn-GFP mouse line, which overexpresses wild-type human α-synuclein protein. We discovered that curcumin diet intervention significantly improved gait impairments and resulted in an increase in phosphorylated forms of α-synuclein at cortical presynaptic terminals. Acute curcumin treatment also caused an increase in phosphorylated α-synuclein in terminals, but had no direct effect on α-synuclein aggregation, as measured by in vivo multiphoton imaging and Proteinase-K digestion. Using LC-MS/MS, we detected ∼5 ng/mL and ∼12 ng/mL free curcumin in the plasma of chronic or acutely treated mice, with a glucuronidation rate of 94% and 97%, respectively. Despite the low plasma levels and extensive metabolism of curcumin, these results show that dietary curcumin intervention correlates with significant behavioral and molecular changes in a genetic synucleinopathy mouse model that mimics human disease.

Original languageEnglish (US)
Article numbere0128510
JournalPLoS One
Volume10
Issue number6
DOIs
StatePublished - Jun 2 2015

Fingerprint

Synucleins
Curcumin
curcumin
Transgenic Mice
genetically modified organisms
mice
animal models
Agglomeration
Neurodegenerative diseases
curry
Plasmas
Endopeptidase K
Spices
Presynaptic Terminals
neurodegenerative diseases
gait
Nutrition
spices
Gait
human diseases

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Curcumin treatment improves motor behavior in α-synuclein transgenic mice. / Spinelli, Kateri J.; Osterberg, Valerie R.; Meshul, Charles K.; Soumyanath, Amala; Unni, Vivek.

In: PLoS One, Vol. 10, No. 6, e0128510, 02.06.2015.

Research output: Contribution to journalArticle

Spinelli, Kateri J. ; Osterberg, Valerie R. ; Meshul, Charles K. ; Soumyanath, Amala ; Unni, Vivek. / Curcumin treatment improves motor behavior in α-synuclein transgenic mice. In: PLoS One. 2015 ; Vol. 10, No. 6.
@article{2a4fa5838db242e98b54637ed2127615,
title = "Curcumin treatment improves motor behavior in α-synuclein transgenic mice",
abstract = "The curry spice curcumin plays a protective role in mouse models of neurodegenerative diseases, and can also directly modulate aggregation of α-synuclein protein in vitro, yet no studies have described the interaction of curcumin and α-synuclein in genetic synucleinopathy mouse models. Here we examined the effect of chronic and acute curcumin treatment in the Syn-GFP mouse line, which overexpresses wild-type human α-synuclein protein. We discovered that curcumin diet intervention significantly improved gait impairments and resulted in an increase in phosphorylated forms of α-synuclein at cortical presynaptic terminals. Acute curcumin treatment also caused an increase in phosphorylated α-synuclein in terminals, but had no direct effect on α-synuclein aggregation, as measured by in vivo multiphoton imaging and Proteinase-K digestion. Using LC-MS/MS, we detected ∼5 ng/mL and ∼12 ng/mL free curcumin in the plasma of chronic or acutely treated mice, with a glucuronidation rate of 94{\%} and 97{\%}, respectively. Despite the low plasma levels and extensive metabolism of curcumin, these results show that dietary curcumin intervention correlates with significant behavioral and molecular changes in a genetic synucleinopathy mouse model that mimics human disease.",
author = "Spinelli, {Kateri J.} and Osterberg, {Valerie R.} and Meshul, {Charles K.} and Amala Soumyanath and Vivek Unni",
year = "2015",
month = "6",
day = "2",
doi = "10.1371/journal.pone.0128510",
language = "English (US)",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Curcumin treatment improves motor behavior in α-synuclein transgenic mice

AU - Spinelli, Kateri J.

AU - Osterberg, Valerie R.

AU - Meshul, Charles K.

AU - Soumyanath, Amala

AU - Unni, Vivek

PY - 2015/6/2

Y1 - 2015/6/2

N2 - The curry spice curcumin plays a protective role in mouse models of neurodegenerative diseases, and can also directly modulate aggregation of α-synuclein protein in vitro, yet no studies have described the interaction of curcumin and α-synuclein in genetic synucleinopathy mouse models. Here we examined the effect of chronic and acute curcumin treatment in the Syn-GFP mouse line, which overexpresses wild-type human α-synuclein protein. We discovered that curcumin diet intervention significantly improved gait impairments and resulted in an increase in phosphorylated forms of α-synuclein at cortical presynaptic terminals. Acute curcumin treatment also caused an increase in phosphorylated α-synuclein in terminals, but had no direct effect on α-synuclein aggregation, as measured by in vivo multiphoton imaging and Proteinase-K digestion. Using LC-MS/MS, we detected ∼5 ng/mL and ∼12 ng/mL free curcumin in the plasma of chronic or acutely treated mice, with a glucuronidation rate of 94% and 97%, respectively. Despite the low plasma levels and extensive metabolism of curcumin, these results show that dietary curcumin intervention correlates with significant behavioral and molecular changes in a genetic synucleinopathy mouse model that mimics human disease.

AB - The curry spice curcumin plays a protective role in mouse models of neurodegenerative diseases, and can also directly modulate aggregation of α-synuclein protein in vitro, yet no studies have described the interaction of curcumin and α-synuclein in genetic synucleinopathy mouse models. Here we examined the effect of chronic and acute curcumin treatment in the Syn-GFP mouse line, which overexpresses wild-type human α-synuclein protein. We discovered that curcumin diet intervention significantly improved gait impairments and resulted in an increase in phosphorylated forms of α-synuclein at cortical presynaptic terminals. Acute curcumin treatment also caused an increase in phosphorylated α-synuclein in terminals, but had no direct effect on α-synuclein aggregation, as measured by in vivo multiphoton imaging and Proteinase-K digestion. Using LC-MS/MS, we detected ∼5 ng/mL and ∼12 ng/mL free curcumin in the plasma of chronic or acutely treated mice, with a glucuronidation rate of 94% and 97%, respectively. Despite the low plasma levels and extensive metabolism of curcumin, these results show that dietary curcumin intervention correlates with significant behavioral and molecular changes in a genetic synucleinopathy mouse model that mimics human disease.

UR - http://www.scopus.com/inward/record.url?scp=84934894524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934894524&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0128510

DO - 10.1371/journal.pone.0128510

M3 - Article

C2 - 26035833

AN - SCOPUS:84934894524

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e0128510

ER -